European stocks opened slightly lower, with the Stoxx 50 index in Europe down 0.1%, DAX index in Germany up 0.2%, FTSE 100 index in Britain down 0.1% and CAC 40 index in France down 0.1%.Puli Pharmaceutical Co., Ltd.: It won the bid for the tenth batch of national centralized drug procurement. According to Puli Pharmaceutical, on December 12, Puli Pharmaceutical's meglumine gadolinium tetate injection (trade name: Puli Yingxian) and Posaconazole injection (trade name: Puli Posa) both won the bid for the tenth batch of national centralized drug procurement.According to the local government, Russia attacked the energy facilities in the Lviv region in western Ukraine.
On the 13th, caustic soda dropped by 3.03%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, the main contract caustic soda 2501 closed, with a turnover of 57,100 lots. The position data showed that the top 20 seats were clear, and the difference position was 1,383 lots. The total contract turnover of caustic soda futures was 94,800 lots, an increase of 27,900 lots over the previous day. The first 20 seats in the contract held 71,100 lots, an increase of 2,202 lots over the previous day. Short positions in the top 20 seats of the contract were 72,700 lots, an increase of 1,157 lots over the previous day. (Sina Futures)Kunlun Unicom and Anheng Information signed a cooperation agreement. On December 11th, Beijing Kunlun Unicom Technology Development Co., Ltd. and Anheng Information signed a cooperation agreement for Beijing regional general generation in Beijing. In this cooperation, Kunlun Unicom will rely on Anheng Information's professional technology and products in the field of digital security to further enrich its solution system and provide customers with more comprehensive information technology services. At the same time, Anheng Information will also rely on Kunlun Unicom's extensive customer resources and market channels to expand its market business in Beijing.Anhui procuratorate prosecuted Huawei Yu, the former deputy general manager of Anhui Investment Group Holding Co., Ltd., for allegedly accepting bribes. According to the highest inspection news, a few days ago, Huawei Yu, the former party member and deputy general manager of Anhui Investment Group Holding Co., Ltd., was suspected of accepting bribes, and the Huainan Municipal People's Procuratorate filed a public prosecution with the Huainan Intermediate People's Court according to law after the jurisdiction designated by the Anhui Provincial People's Procuratorate. The case is being further processed. At the stage of examination and prosecution, the procuratorial organ informed the defendant Huawei Yu of his litigation rights according to law, interrogated the defendant according to law and listened to the opinions of defenders. The People's Procuratorate of Huainan City charged that the defendant Huawei Yu, as a national staff member, used the convenience of his position and the convenience of his authority or position to seek benefits for others through the actions of other national staff members, and illegally accepted other people's property alone or in collusion with others. The amount was extremely huge, so he should be investigated for criminal responsibility for accepting bribes according to law.
To ensure that patients across the country will use the drugs selected in April next year, the tenth batch of drugs organized by the state will be opened for centralized procurement, and the tenth batch of drugs organized by the state will be selected in Shanghai yesterday, and 62 drugs will be purchased successfully. Covering hypertension, diabetes, tumors, cardiovascular and cerebrovascular diseases, infections, mental diseases and other fields. In the next step, the National Medical Insurance Bureau will guide local and selected enterprises to do a good job in the implementation of the selected results to ensure that patients across the country can use the selected products in this centralized collection in April 2025. (CCTV News)Puli Pharmaceutical Co., Ltd.: It won the bid for the tenth batch of national centralized drug procurement. According to Puli Pharmaceutical, on December 12, Puli Pharmaceutical's meglumine gadolinium tetate injection (trade name: Puli Yingxian) and Posaconazole injection (trade name: Puli Posa) both won the bid for the tenth batch of national centralized drug procurement.Namibia's GDP in the third quarter increased by 2.8% year on year.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14